Clinical trial
Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in…
NCT00231153 · Cadence Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00231153 |
|---|---|
| Title | Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters |
| Official title | A Phase 3, Multicenter, Randomized, Evaluation Committee-Blinded Study to Assess the Efficacy of Topical Omiganan 1% Gel in Preventing Local Catheter Site Infections/Colonization in Patients Undergoing Central Venous Catheterization |
| Lead sponsor | Cadence Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection |
| Intervention type | Drug |
| Interventions | Omiganan 1% gel, Povidone-Iodine 10% |
| Enrollment | 1,859 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 4, 2005 |
| Last update posted | Aug 13, 2009 |
| Countries | France, Germany, Spain, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: